Xgeva — Medica
Bone metastases from solid tumors – prevention of skeletal-related events
Initial criteria
- Patient is age ≥ 18 years
- Patient has bone metastases
- If patient has prostate cancer, disease must be castration-resistant
- Medication is prescribed by or in consultation with a hematologist or an oncologist
Approval duration
1 year